Education
About Us
Working with TipRanks
Follow Us
BioNexus Gene Lab Corp (BGLC)
NASDAQ:BGLC
BGLC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.01 - $8.40
Previous Close$0.33
Volume739.27K
Average Volume (3M)1.25M
Market Cap
$4.80M
Enterprise ValueN/A
Total Cash (Recent Filing)$839.14K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.92
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.89
Shares Outstanding1,796,766
10 Day Avg. Volume3,468,139
30 Day Avg. Volume1,252,774
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.55
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
BioNexus Gene Lab Corp News
PremiumMarket News
3 Penny Stocks to Watch Now, 4/15/25
PremiumCompany Announcements
BioNexus Gene Lab Faces Delisting and Leadership Changes
---
Ownership Overview
―
Insiders
1.32%
Mutual Funds
0.06% Other Institutional Investors
98.68% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
BGLC FAQ
What was BioNexus Gene Lab Corp’s price range in the past 12 months?
BioNexus Gene Lab Corp lowest stock price was $2.01 and its highest was $8.40 in the past 12 months.
What is BioNexus Gene Lab Corp’s market cap?
BioNexus Gene Lab Corp’s market cap is $4.80M.
When is BioNexus Gene Lab Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioNexus Gene Lab Corp’s earnings last quarter?
Currently, no data Available
Is BioNexus Gene Lab Corp overvalued?
According to Wall Street analysts BioNexus Gene Lab Corp’s price is currently Overvalued.
Does BioNexus Gene Lab Corp pay dividends?
BioNexus Gene Lab Corp does not currently pay dividends.
What is BioNexus Gene Lab Corp’s EPS estimate?
BioNexus Gene Lab Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioNexus Gene Lab Corp have?
BioNexus Gene Lab Corp has 1,796,766 shares outstanding.
What happened to BioNexus Gene Lab Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioNexus Gene Lab Corp?
Currently, no hedge funds are holding shares in BGLC
---
BioNexus Gene Lab Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.48%
12-Months-Change
Fundamentals
Return on Equity
-17.78%
Trailing 12-Months
Asset Growth
-8.47%
Trailing 12-Months
Company Description
BioNexus Gene Lab Corp
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
---
Technical Analysis
Applied DNA Sciences
―
Precipio
―
ENDRA Life Sciences
―
Intelligent Bio Solutions
―
iSpecimen
―
---